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tions in a three-star hotel, all meals, a boat tour with Professor Vladimir Tesar, Division of Nephrology, 1st
Department of Medicine, Charles University, U nemoc-dinner on the Danube, and all other social programs.
The number of participants is limited. For further infor- nice 2, 128 08 Prague 2, Czech Republic. Telephone/Fax:
00420224962696; E-mail: tesarv@beba.cesnet.cz, or themation and application, please contact: Lszlo Rosivall,
M.D., Ph.D., D.Sc., Professor of Pathophysiology, Sem- Web site: http://www.anca2003.org
melweis University, Institute of Pathophysiology, Ne-
phrology Research and Training Center, Nagyvarad ter
AWARDS AND GRANTS
4, 1089 Budapest, Hungary. Fax:361-2100-100; E-mail:
Grand Hamdan International Award in the field ofrosivall@net.sote.hu
Renal Diseases: Pathogenesis and ManagementThe First Renal Failure Academy will be held Septem-
ber 19–21, 2003, at the World Trade Center in Iasi, Ro- The General Secretariat is pleased to invite doctors,
researchers, universities, research centers, and medicalmania. Its primary focus is for young nephrologists from
all Eastern European countries. Speakers with internati- scientific societies throughout the world to nominate
qualified candidates for the award for 2003-2004. Thenal reputations will present information on clinical ne-
phrology, hypertension, and dialysis and transplantation, amount of the award is $80,000 US. Closing date for
nominations is December 31, 2003. For further informa-focusing on evidence-based medicine and therapeutic
options in acute and chronic renal failure. The format tion and application forms, please contact: The General
Secretariat, Sheikh Hamdam Bin Rashid Al Maktoumwill provide interactive sessions and workshops. Most of
the expenses (travel cost, accommodations, and educa- Award for Medical Sciences, P.O. Box 2252, Dubai,
United Arab Emirates. Telephone:971 4 2275 888; Fax:tional materials) will be covered by the organizers. The
registration fee is 50 Euro. The number of participants 971 4 2273 938/2272 999; E-mail: shhaward@emirates.
net.ae; Web site: http:/www.hmaward.org.aeis limited. This meeting has the support of the ERA-
EDTA, ISN/COMGAN, Joint Action Nephrology East-
Hospal Diabetes and Dialysis Research Programern Europe, and the Romanian Society of Nephrology.
Young nephrologists should submit an application and The first annual Hospal research awards are being
announced. Hospal, a world leader in renal replacementCV to Associate Professor Adrian Covic, M.D., Ph.D.,
Nephrology Clinic, Parhon University Hospital, Carol therapy, has created Hospal research funding to support
clinical studies, this year, focusing on cardiovascular risk1st Blvd. 50, Iasi 6600 Romania. Telephone/Fax: 30-
232-210490; E-mail: acovic@xnet.ro management in dialysis, particularly in the diabetes pa-
tient. Diabetes is a major risk factor for end-stage renalThe Second International Conference on the Prevention
of Renal Disease will be held September 19–20, 2003, in disease patients and cardiovascular disease continues to
be the main cause of death. For many years, HospalToronto, Ontario, Canada. This conference is organized
by the Divisions of Nephrology, University Health Net- has been investigating innovative therapies in this area,
spreading knowledge through symposiums and educatorwork, Sunnybrook & Women’s College, Health Sciences
Centre and St. Michael’s Hospital. The course director sessions. The Hospal research funding is intended to
support innovative patient-oriented clinical research,is Dimitrios G. Oreopoulos. For further information,
contact: Dimitrios G. Oreopoulos, M.D. Telephone: 416- proposed by physicians and researchers involved in this
field. For complete information and applications, please603-7974; Fax: 416-603-8127; E-mail: Sandra.Medeiros@
uhn.on.ca; Web site: www.neproprevention.com contact http:/www.hospal.com
The Third International Congress on Uremia Research
The Bernd Tersteegen Award 2003will be held October 2–4, 2003, in Taormina, Sicily. The
deadline for submission of abstracts is May 2, 2003. For The Deutsche Dialysegesellschaft niedergelassener
A¨rzte e. V. (DDnA¨), the German Society of Nephrolo-further information, contact: Professor Guido Bellin-
ghieri, Viale Regina Margherita 69, 98100 Messina, Sicily, gists in Private Practice, would like to announce the
Bernd Tersteegen Award 2003.Italy. Fax: 39-090-36-36-36.
The 11th International ANCA and Vasculitis Work- The award (8,000 Euro) is sponsored by Hoffmann-
La Roche AG (Grenzach-Wyhlen/Germany) and will beshop will be held October 2–5, 2003, in Prague, Czech
Republic. The main topics of the workshop will be the given annually.
Only original scientific papers either published in theetiology and pathogenesis of vasculitis, the current place
of antineutrophil cytoplasmic antibodies (ANCA) in the last year (2002 to 2003) or as yet unpublished will be
accepted. Papers should be written in German or En-diagnosis and monitoring of disease activity and clinical
studies in vasculitis. A postgraduate course will be orga- glish. Reviews and dissertations will not be accepted nor
will works already entered in other competitions. If thenized on October 5, 2003. The meeting is co-sponsored
by the Czech Society of Nephrology and European Vas- submitted paper is the work of multiple authors, a single
speaker should be chosen to represent the group. Aculitis Study Group. For further information, contact:
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curriculum vitae in a shortened form, as well as a list of pledge from Mr. Thomas Kaplan of New York in honor
of his late mother Lillian Jean Kaplan who died of thepublications to date, should also be submitted.
Five copies of the submitted paper, curriculum vitae, disease last year. The prize was created to recognize
those who have increased our understanding and treat-and publication list should be sent by July 15, 2003, to
Duetsche Dialysegesellschaft niedergelassener A¨rzte e. V., ment of PKD and to stimulate interest in advancing
research that will lead to new treatments and a cure forDr. med. Werner Kleophas, President, Postfach 132304,
D 42050 Wuppertal. the disease.
Thanks to the outstanding generosity of Mr. Kaplan,The award will be presented at the Annual Meeting in
2003 of the DDnA¨ on November 8, 2003, in Mannheim. this year the full prize of $50,000 is being exceptionally
awarded twice in recognition of research carried out byApplicants, physicians, or basic scientists should be
engaged in either clinical or basic research in the field two eminent nephrologists.
Jared J. Grantham, M.D., University Distinguishedof nephrology. If the case arises, the award may be
shared, but should, however, be focused upon one suc- Professor of the University of Kansas Medical Center
and Director of the Kidney Institute at the Center, Kan-cessful applicant. Applicants may be emcompassed or
engaged in any of the following studies: kidney failure sas City, KS (USA), and Peter Harris, M.D., Professor
of Biochemistry/Molecular Biology and Medicine, Mayoand kidney therapy in the clinic, surgery, or research
physicians in laboratories, scientists, or graduated engi- Medical School and Consultant, Department of Medi-
cine, Division of Nephrology, Mayo Clinic, Rochester,neers.
MN (USA) were selected from among eight nominees
Polycystic Kidney Disease (PKD) Research Request from around the globe.
for Applications The International Research Advisory Committee,
chaired by Dr. Nathan Levin of the Renal ResearchThe PKD Foundation is currently requesting applica-
Institute in New York and comprising two representa-tions for one or two-year grants for basic or clinical
tives of the ISN, Dr. John H. Dirks, Chair, ISN COM-research for research on autosomal-dominant polycystic
GAN, Toronto (Canada) and Dr. Pierre Ronco of Hoˆpi-kidney disease (ADPKD) and/or autosomal-recessive
tal Tenon, Paris (France), and two representatives ofpolycystic kidney disease (ARPKD). An extension for a
the PKD Foundation, Dr. Vicente Torres, and Dr. Lisathird year is possible. The $65,000 grants will be awarded
Guay-Woodford, Chair and Vice-Chair, respectively, ofin December 2003. Fellowship awards of $50,000 are also
the PKD Foundation Scientific Advisory Committee,available and will be awarded in July 2004. Complete
were unanimous in their choice of winners for this prize.application and guideline information is available on line
Dr. Grantham was selected for his major research contri-at www.pkdcure.org or by contacting Karla Bredehoeft
bution and particularly for his outstanding leadership inat the PKD Foundation at (800) PKD-CURE (753-2873).
PKD and Dr. Harris for his original research in PKD andApplications are due on or before August 1, 2003.
particularly for the identification and complete cloning of
the PKD1 gene.
ANNOUNCING THE WINNERS OF THE ISN Dr. Grantham and Dr. Harris will be honored during
INTERNATIONAL PRIZES the Official Prize Ceremony to be held at 2:00 p.m. on
ISN has recently introduced two new prizes to stimu- Monday, June 9 in Berlin. In the presence of Dr. Robert
late scientific research to identify treatment, cures and C. Atkins, President of ISN and Dr. Dan Larson, Presi-
therapeutic advances in kidney disease. These significant dent and CEO of the PKD Foundation, Mr. Thomas
prizes of $50,000 each are to be awarded every two years Kaplan will bestow each of them with their prize check.
during the Society’s World Congress of Nephrology This will be followed by a 30-minute presentation of
(WCN), starting with the WCN in Berlin, Germany, June the scientific findings from each of the prize winners.
8–12, 2003. “Understanding Polycystic Kidney Disease: A Systems
Biology Approach” will be presented by Dr. Grantham
The Lillian Jean Kaplan International Prize for while Dr. Harris will focus on “Understanding Polycystic
Advancement in the Understanding of Polycystic Kidney Disease: A Genetic Approach.”
Kidney Disease (PKD)
The AMGEN Inc. International Prize for TherapeuticThe International Society of Nephrology (ISN) and
Advancement in Nephrologythe PKD Foundation are proud to announce the winners
of the inaugural Lillian Jean Kaplan International The International Society of Nephrology (ISN) is de-
Prize for Advancement in the Understanding of Polycys- lighted to announce the first winner of the AMGEN Inc.
tic Kidney Disease (PKD). International Prize for Therapeutic Advancement in Ne-
The ISN/PKD Foundation Lillian Jean Kaplan Inter- phrology.
The ISN AMGEN Inc. International Prize was estab-national Prize was established by way of a generous
